Page last updated: 2024-10-25
clofibric acid and Biliary Cirrhosis
clofibric acid has been researched along with Biliary Cirrhosis in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Ursodeoxycholic acid the standard treatment of primary biliary cirrhosis improves the cholestasis and hereby lowers circulating levels of cholesterol." | 2.44 | Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated. ( Balmer, ML; Dufour, JF, 2008) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Balmer, ML | 1 |
| Dufour, JF | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Liver Injury by Statins in Coronary Heart Disease (CHD) Patients With History of Hepatitis B Virus (HBV) Infection[NCT02808299] | | 600 participants (Anticipated) | Observational | 2016-12-31 | Not yet recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
1 review available for clofibric acid and Biliary Cirrhosis